LENSAR Inc. (LNSR)
13.91
0.16 (1.16%)
At close: Apr 17, 2025, 3:59 PM
13.88
-0.19%
After-hours: Apr 17, 2025, 04:20 PM EDT
1.16% (1D)
| Bid | 13.37 |
| Market Cap | 164M |
| Revenue (ttm) | 53.49M |
| Net Income (ttm) | -31.4M |
| EPS (ttm) | -2.73 |
| PE Ratio (ttm) | -5.1 |
| Forward PE | -126.45 |
| Analyst | Hold |
| Ask | 14.75 |
| Volume | 89,193 |
| Avg. Volume (20D) | 174,596 |
| Open | 13.79 |
| Previous Close | 13.75 |
| Day's Range | 13.67 - 13.93 |
| 52-Week Range | 2.95 - 17.31 |
| Beta | 0.56 |
About LNSR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, d...
Industry Medical - Devices
Sector Healthcare
IPO Date Oct 2, 2020
Employees 140
Stock Exchange NASDAQ
Ticker Symbol LNSR
Website https://www.lensar.com
Analyst Forecast
According to 1 analyst ratings, the average rating for LNSR stock is "Hold." The 12-month stock price forecast is $15, which is an increase of 7.84% from the latest price.
Stock ForecastsNext Earnings Release
LENSAR Inc. is scheduled to release its earnings on May 8, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+19.6%
LENSAR shares are trading higher after Lake Street...
Unlock content with
Pro Subscription
1 month ago
+14.78%
Lensar shares are trading higher after the company issued FY25 revenue guidance above estimates.
